California Public Employees Retirement System’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,084
Closed -$239K 1532
2021
Q1
$239K Hold
5,084
﹤0.01% 3306
2020
Q4
$200K Sell
5,084
-455
-8% -$15.5K ﹤0.01% 3348
2020
Q3
$141K Buy
5,539
+260
+5% +$16.4K ﹤0.01% 3325
2020
Q2
$385K Buy
5,279
+3,687
+232% +$255K ﹤0.01% 2854
2020
Q1
$84K Hold
1,592
﹤0.01% 3146
2019
Q4
$130K Hold
1,592
﹤0.01% 3228
2019
Q3
$90K Hold
1,592
﹤0.01% 3110
2019
Q2
$190K Sell
1,592
-248
-13% -$41.6K ﹤0.01% 2940
2019
Q1
$339K Hold
1,840
﹤0.01% 2725
2018
Q4
$328K Hold
1,840
﹤0.01% 2726
2018
Q3
$589K Sell
1,840
-380
-17% -$135K ﹤0.01% 2595
2018
Q2
$888K Buy
2,220
+1,212
+120% +$530K ﹤0.01% 2390
2018
Q1
$362K Sell
1,008
-399
-28% -$148K ﹤0.01% 2760
2017
Q4
$557K Buy
+1,407
New +$582K ﹤0.01% 2606

Other funds holding ABEO

California Public Employees Retirement System's ABEO Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Abeona Therapeutics (ABEO) in Q2 2021, closing a stake of 5,084 shares — an estimated $239K sold.

California Public Employees Retirement System first reported a position in ABEO in Q4 2017 and held it in 14 quarters. The position peaked at $888K in Q2 2018. 70 funds tracked by Wall St. Rank hold ABEO as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Abeona Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 5,084 Abeona Therapeutics shares in Q2 2021, an estimated $239K.
  • California Public Employees Retirement System first reported a position in Abeona Therapeutics in Q4 2017 and held it in 14 quarters.
  • California Public Employees Retirement System's Abeona Therapeutics position peaked at $888K in Q2 2018.
  • 70 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.